Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02603835 · ClinicalTrials.gov registry record · NA
Evaluation of Intracoronary Hyperoxemic Oxygen Therapy in Anterior Acute Myocardial Infarction Patients (IC-HOT)
A NA study, sponsored by TherOx.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02603835 is a NA study that has completed, run by TherOx. The registered enrollment target is 100 participants.
The verdict
NCT02603835, a NA study, has completed, sponsored by TherOx.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The primary objective of the study is to collect confirmatory data supporting the safety and effectiveness of SSO2 Therapy in treatment of anterior acute myocardial infarction (AMI) patients who have undergone successful percutaneous coronary intervention (PCI) with stenting within six hours of experiencing AMI symptoms.
Interventions
- DEVICE SSO2 Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-05-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02603835
The ClinicalTrials.gov registry entry for NCT02603835 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TherOx, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SSO2 Therapy is the first listed.
NCT02603835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02603835 about?
NCT02603835 is a clinical study titled "Evaluation of Intracoronary Hyperoxemic Oxygen Therapy in Anterior Acute Myocardial Infarction Patients (IC-HOT)". The primary objective of the study is to collect confirmatory data supporting the safety and effectiveness of SSO2 Therapy in treatment of anterior acute myocardial infarction (AMI) patients who have undergone successful percutaneous coronary intervention (PCI) with stenting within six hours of expe...
What is the current status of trial NCT02603835?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2016-02. Estimated completion is 2018-05-17.
What interventions are being tested in trial NCT02603835?
The interventions under investigation include: SSO2 Therapy (DEVICE).
Who is sponsoring clinical trial NCT02603835?
This trial is sponsored by TherOx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.